BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.97 and traded as low as $1.68. BioRestorative Therapies shares last traded at $1.76, with a volume of 36,331 shares changing hands.
BioRestorative Therapies Stock Performance
The business’s 50-day simple moving average is $1.97 and its 200 day simple moving average is $1.71. The firm has a market cap of $12.18 million, a P/E ratio of -1.15 and a beta of 64.37.
About BioRestorative Therapies
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Upcoming IPO Stock Lockup Period, Explained
- 3 ETFs to Ride the VIX Surge During Market Volatility
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
